Sphera Funds Management as of March 31, 2016
Portfolio Holdings for Sphera Funds Management
Sphera Funds Management holds 90 positions in its portfolio as reported in the March 2016 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Select Sector Spdr Tr option | 11.0 | $51M | 750k | 67.78 | |
| Pfizer (PFE) | 9.2 | $42M | 1.4M | 29.64 | |
| Teva Pharmaceutical Industries (TEVA) | 8.4 | $39M | 725k | 53.51 | |
| Biogen Idec (BIIB) | 6.7 | $31M | 119k | 260.32 | |
| Ishares Tr Index option | 6.0 | $28M | 250k | 110.63 | |
| Allergan | 5.8 | $27M | 100k | 268.03 | |
| Shire | 3.6 | $17M | 189k | 87.34 | |
| Gilead Sciences (GILD) | 3.4 | $16M | 173k | 91.86 | |
| Mylan Nv | 2.9 | $13M | 288k | 46.35 | |
| Ormat Technologies (ORA) | 2.9 | $13M | 322k | 41.18 | |
| Celgene Corporation | 2.2 | $10M | 100k | 100.09 | |
| Ituran Location And Control (ITRN) | 2.0 | $9.3M | 472k | 19.68 | |
| Alexion Pharmaceuticals | 1.2 | $5.6M | 40k | 139.22 | |
| Visa (V) | 1.1 | $5.2M | 67k | 76.47 | |
| Select Sector Spdr Tr option | 1.0 | $4.5M | 200k | 22.50 | |
| Alnylam Pharmaceuticals (ALNY) | 0.9 | $4.4M | 70k | 62.77 | |
| Alphabet Inc Class A cs (GOOGL) | 0.9 | $4.3M | 5.7k | 762.85 | |
| Vanda Pharmaceuticals (VNDA) | 0.9 | $4.3M | 512k | 8.36 | |
| ACADIA Pharmaceuticals (ACAD) | 0.9 | $4.2M | 150k | 27.96 | |
| Adamas Pharmaceuticals | 0.8 | $3.9M | 270k | 14.46 | |
| Sage Therapeutics (SAGE) | 0.8 | $3.9M | 123k | 32.06 | |
| Advance Auto Parts (AAP) | 0.7 | $3.2M | 20k | 160.36 | |
| Elbit Systems (ESLT) | 0.7 | $3.2M | 35k | 94.09 | |
| Charter Communications | 0.7 | $3.2M | 16k | 202.45 | |
| Five Prime Therapeutics | 0.7 | $3.2M | 80k | 40.62 | |
| Marinus Pharmaceuticals | 0.7 | $3.1M | 571k | 5.38 | |
| Partner Communications Company | 0.6 | $2.9M | 624k | 4.66 | |
| Macrogenics (MGNX) | 0.6 | $2.9M | 153k | 18.75 | |
| Palo Alto Networks (PANW) | 0.6 | $2.8M | 17k | 163.14 | |
| Genocea Biosciences | 0.6 | $2.8M | 362k | 7.74 | |
| Radius Health | 0.6 | $2.8M | 90k | 31.44 | |
| Neurocrine Biosciences (NBIX) | 0.6 | $2.8M | 70k | 39.56 | |
| Kempharm | 0.6 | $2.7M | 184k | 14.50 | |
| Amicus Therapeutics (FOLD) | 0.6 | $2.5M | 300k | 8.45 | |
| Amicus Therapeutics Inc option | 0.6 | $2.5M | 300k | 8.45 | |
| Dermira | 0.5 | $2.5M | 120k | 20.68 | |
| Eiger Biopharmaceuticals | 0.5 | $2.5M | 148k | 16.77 | |
| Cytokinetics (CYTK) | 0.5 | $2.4M | 342k | 7.05 | |
| Neuroderm Ltd F | 0.5 | $2.3M | 166k | 14.12 | |
| Kite Pharma | 0.5 | $2.3M | 50k | 45.92 | |
| Acadia Pharmaceuticals, Inc. cmn | 0.5 | $2.2M | 80k | 27.96 | |
| Foamix Pharmaceuticals | 0.5 | $2.2M | 342k | 6.52 | |
| Aduro Biotech | 0.5 | $2.2M | 170k | 12.81 | |
| Air Products & Chemicals (APD) | 0.5 | $2.1M | 15k | 144.08 | |
| Chiasma | 0.5 | $2.1M | 231k | 9.16 | |
| Forward Pharma A/s | 0.5 | $2.1M | 122k | 17.00 | |
| Agios Pharmaceuticals (AGIO) | 0.4 | $2.0M | 50k | 40.60 | |
| Glycomimetics (GLYC) | 0.4 | $2.0M | 338k | 5.96 | |
| Mellanox Technologies | 0.4 | $2.0M | 37k | 54.33 | |
| Egalet | 0.4 | $2.0M | 293k | 6.86 | |
| Immune Design | 0.4 | $2.0M | 153k | 13.00 | |
| Acorda Therapeutics | 0.4 | $1.9M | 73k | 26.45 | |
| Israel Chemicals | 0.4 | $1.9M | 438k | 4.35 | |
| Heron Therapeutics (HRTX) | 0.4 | $1.9M | 100k | 18.99 | |
| Arbutus Biopharma (ABUS) | 0.4 | $1.9M | 455k | 4.13 | |
| Raptor Pharmaceutical | 0.4 | $1.8M | 400k | 4.60 | |
| Inotek Pharmaceuticals | 0.4 | $1.9M | 250k | 7.40 | |
| Valeant Pharmaceuticals Int | 0.4 | $1.8M | 69k | 26.31 | |
| Clovis Oncology | 0.4 | $1.8M | 95k | 19.20 | |
| Nice Systems (NICE) | 0.4 | $1.8M | 27k | 64.80 | |
| Wabtec Corporation (WAB) | 0.4 | $1.7M | 22k | 79.29 | |
| Colucid Pharmaceuticals | 0.4 | $1.7M | 278k | 6.20 | |
| Ptc Therapeutics I (PTCT) | 0.3 | $1.6M | 250k | 6.44 | |
| Portola Pharmaceuticals | 0.3 | $1.6M | 80k | 20.40 | |
| Cynapsus Therapeutics | 0.3 | $1.6M | 134k | 11.90 | |
| Ionis Pharmaceuticals (IONS) | 0.3 | $1.6M | 40k | 40.50 | |
| Corvus Pharmaceuticals (CRVS) | 0.3 | $1.6M | 111k | 14.50 | |
| Orbotech Ltd Com Stk | 0.3 | $1.6M | 66k | 23.79 | |
| Alder Biopharmaceuticals | 0.3 | $1.5M | 63k | 24.50 | |
| Pieris Pharmaceuticals | 0.3 | $1.5M | 810k | 1.90 | |
| Summit Therapeutics Plc spons ads | 0.3 | $1.4M | 199k | 7.00 | |
| Edge Therapeutics | 0.3 | $1.4M | 150k | 9.15 | |
| Bluebird Bio (BLUE) | 0.3 | $1.3M | 30k | 42.50 | |
| Palatin Technologies | 0.3 | $1.2M | 2.3M | 0.54 | |
| Scynexis | 0.3 | $1.2M | 305k | 4.03 | |
| Trillium Therapeutics, Inc. Cmn | 0.3 | $1.2M | 132k | 9.25 | |
| Abeona Therapeutics | 0.3 | $1.2M | 468k | 2.56 | |
| Catabasis Pharmaceuticals | 0.2 | $1.2M | 230k | 5.04 | |
| Catalyst Pharmaceutical Partners (CPRX) | 0.2 | $1.1M | 905k | 1.17 | |
| Portola Pharmaceuticals | 0.2 | $1.0M | 50k | 20.40 | |
| Aldeyra Therapeutics (ALDX) | 0.2 | $999k | 239k | 4.19 | |
| Axsome Therapeutics (AXSM) | 0.2 | $938k | 109k | 8.60 | |
| Mannkind Corp | 0.2 | $746k | 464k | 1.61 | |
| Internet Gold - Golden Lines L Com Stk | 0.1 | $678k | 50k | 13.49 | |
| Ocera Therapeutics | 0.1 | $549k | 187k | 2.94 | |
| Nivalis Therapeutics | 0.1 | $333k | 80k | 4.17 | |
| Tobira Therapeutics Inc Common Stock Usd 0.0001 | 0.1 | $264k | 32k | 8.17 | |
| Strongbridge Bioph shs usd | 0.1 | $277k | 61k | 4.56 | |
| Ellomay Capital (ELLO) | 0.0 | $48k | 5.7k | 8.49 | |
| Tower Semiconductor (TSEM) | 0.0 | $0 | 0 | 0.00 |
